Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis▿

Overview of attention for article published in Journal of Virology, November 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent: 2 patents
facebook: 1 Facebook page

wikipedia: 5 Wikipedia pages

Citations

dimensions_citation: 125 Dimensions

Readers on

mendeley: 106 Mendeley

Summary Patents Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Epstein-Barr-virus vaccine

Grant US-10300129-B2

United States of America

AN EPSTEIN-BARR-VIRUS VACCINE

Application WO-2012025603-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.